Senate Judiciary Committee Chairman Richard Durbin (D-IL). Photo: Diego M. Radzinschi/ALM

The U.S. Food and Drug Administration is under pressure to boost oversight of online prescription drug promotions amid the rise of social media influencers and their potential to convey misinformation to vulnerable patients and impressionable teens.

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

  • Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and events
  • Access to other award-winning ALM websites including and

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.